Atrial fibrillation (AF) is the most common arrhythmia seen around the world. More than 12 million people in the United States will have AF by 2030, quintupling their risk for severe ischemic strokes. While the introduction of direct oral anticoagulants (DOACs) has enhanced stroke prophylaxis in AF, these medications are not equitably offered to all individuals, for a variety of reasons – both explicit and implicit.
In this CME Outfitters BriefCase activity, an expert faculty follows the journey of a 48-year-old Black female with AF to illuminate disparities in the quality of care she is offered. Frank questions and candid discussions about the impact of implicit bias, social determinants of health, shared decision making, and health literacy provide actionable and individualized strategies to improve outcomes for all patients with AF.
At the end of this CME/CE activity, participants should be able to identify the impact of health inequities in cardiology patients with atrial fibrillation; individualize a holistic treatment plan for cardiology care to improve patient outcomes.
Supported by an educational grant from Johnson & Johnson.
Physicians, physician associates (PAs), nurse practitioners (NPs), nurses, pharmacists, specializing in cardiology, surgery, primary care, or emergency medicine
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Peek reports the following financial relationships: Consultant: Pfizer Inc.
Dr. Bond reports no financial relationships to disclose.
Dr. Essien reports the following financial relationships: Grants: Department of Veterans Affairs Health Services Research and Development Division.
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-22-125-H01-P